Salarius Pharmaceuticals Inc Long-term Investment Intensity

Latest as of December 2015: 2.4%

Salarius Pharmaceuticals Inc long-term investment intensity. Salarius Pharmaceuticals Inc (SLRX) has a Long-term Investment Intensity of 2.4% as of December 2015. Long-term investments of $2.31 Million represent 2.4% of total assets of $95.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Salarius Pharmaceuticals Inc debt and liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

2.4%
LT Investments / Total Assets

Long-term Investments

$2.31 Million
USD

Total Assets

$95.07 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Salarius Pharmaceuticals Inc (2015–2015)

Long-term investment intensity of Salarius Pharmaceuticals Inc from 2015 to 2015. This chart shows how Salarius Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2015 to 2015. As of December 2015, the intensity stands at 2.4%, reflecting long-term investments of $2.31 Million against total assets of $95.07 Million USD.

Salarius Pharmaceuticals Inc Long-term Investment Intensity by Year (2015–2015)

Salarius Pharmaceuticals Inc long-term investment intensity by year from 2015 to 2015. The table below presents the year-by-year Long-term Investment Intensity for Salarius Pharmaceuticals Inc from 2015 to 2015, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Salarius Pharmaceuticals Inc assets under control.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2015 2.4% $2.31 Million $95.07 Million —
pp = percentage points